» Articles » PMID: 30742686

Biochemical Metabolic Levels and Vitamin D Receptor FokⅠ Gene Polymorphisms in Uyghur Children with Urolithiasis

Overview
Journal PLoS One
Date 2019 Feb 12
PMID 30742686
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Because of lacking studies of urolithiasis in children, we detected the biochemical metabolic levels and FokⅠ polymorphisms in the vitamin D receptor (VDR) in Uyghur children with urolithiasis, and evaluated the associations of biochemical metabolic levels with FokⅠ genotypes. We included 142 Uyghur children (108 males) under age 14 years with a diagnosis of urolithiasis and 238 Uyghur children (154 males) under age 14 years without a history of urolithiasis as controls. Baseline information and data for serum and urine parameters were obtained from medical records. PCR-restriction fragment length polymorphism (PCR-RFLP) was used to analyze the VDR FokⅠ polymorphisms. In univariate analyses adjusting for age and sex, carbon dioxide combining power (CO2CP) (odds ratio [OR] = 1.13, 95% confidence interval [CI]: 1.07-1.19), serum magnesium (Mg) (OR = 1.27, 95% CI: 1.03-1.56) and serum chlorine (Cl) (OR = 0.93, 95% CI: 0.88-0.97) were related to Uyghur children urolithiasis risk. A multiple logistic regression model showed CO2CP (OR = 1.17, 95% CI: 1.09-1.26), levels of uric acid (OR = 1.01, 95% CI: 1.00-1.01) and serum sodium (Na) (OR = 0.90, 95% CI: 0.82-0.99) were associated with pediatric urolithiasis. The risk of urolithiasis was increased with the F versus f allele overall (OR = 1.42; 95% CI: 1.01-2.00) and for males (OR = 1.52, 95% CI: 1.02-2.27). However, metabolic levels did not differ by FokⅠ genotypes. In our population, CO2CP and levels of uric acid and serum Na as well as polymorphism of the F allele of the VDR FokⅠ may provide important clues to evaluate the risk of urolithiasis in Uyghur children.

Citing Articles

Genetic Polymorphisms and Kidney Stones Around the Globe: A Systematic Review and Meta-Analysis.

Mohammadi A, Namazi Shabestari A, Zareian Baghdadabad L, Khatami F, Reis L, Pishkuhi M Front Genet. 2022; 13:913908.

PMID: 35846117 PMC: 9280078. DOI: 10.3389/fgene.2022.913908.


Vitamin D receptor gene polymorphisms and susceptibility to urolithiasis: a meta-regression and meta-analysis.

Imani D, Razi B, Khosrojerdi A, Lorian K, Motallebnezhad M, Rezaei R BMC Nephrol. 2020; 21(1):263.

PMID: 32650740 PMC: 7350604. DOI: 10.1186/s12882-020-01919-1.


Relationship Between the (rs7975232), (rs1544410), (rs2228570), and (rs731236) Variants in the Vitamin D Receptor Gene and Urolithiasis Susceptibility: An Updated Meta-Analysis and Trial Sequential Analysis.

Chen G, Hu C, Song Y, Xiu M, Liang W, Ou N Front Genet. 2020; 11:234.

PMID: 32346382 PMC: 7175806. DOI: 10.3389/fgene.2020.00234.

References
1.
Sas D . An update on the changing epidemiology and metabolic risk factors in pediatric kidney stone disease. Clin J Am Soc Nephrol. 2011; 6(8):2062-8. DOI: 10.2215/CJN.11191210. View

2.
Wumaner A, Keremu A, Wumaier D, Wang Q . High incidence of urinary stones in Uyghur children may be related to local environmental factors. J Pediatr Urol. 2013; 10(2):289-93. DOI: 10.1016/j.jpurol.2013.09.002. View

3.
Karnauskas A, van Leeuwen J, van den Bemd G, Kathpalia P, Deluca H, Bushinsky D . Mechanism and function of high vitamin D receptor levels in genetic hypercalciuric stone-forming rats. J Bone Miner Res. 2005; 20(3):447-54. DOI: 10.1359/JBMR.041120. View

4.
Gajengi A, Wagaskar V, Tanwar H, Mhaske S, Patwardhan S . Metabolic Evaluation in Paediatric Urolithiasis: A 4-Year Open Prospective Study. J Clin Diagn Res. 2016; 10(2):PC04-6. PMC: 4800581. DOI: 10.7860/JCDR/2016/17265.7251. View

5.
Cakir O, Yilmaz A, Demir E, Incekara K, Kose M, Ersoy N . Association of the BsmI, ApaI, TaqI, Tru9I and FokI Polymorphisms of the Vitamin D Receptor Gene with Nephrolithiasis in the Turkish Population. Urol J. 2016; 13(1):2509-18. View